Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
about
The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal functionPheochromocytomas and Paragangliomas: Clinical and Genetic ApproachesTarget therapy in metastatic pheochromocytoma: current perspectives and controversiesIntegrative analysis of neuroblastoma and pheochromocytoma genomics data.Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.Current views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaAnti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.Molecular markers of paragangliomas/pheochromocytomasMitochondrial Deficiencies in the Predisposition to ParagangliomaCurrent approaches and recent developments in the management of head and neck paragangliomas.Identity by descent mapping of founder mutations in cancer using high-resolution tumor SNP data.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentThe size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort studyComprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.P.Arg82Leu von Hippel-Lindau (VHL) gene mutation among three members of a family with familial bilateral pheochromocytoma in India: molecular analysis and in silico characterization.Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.Role of miR-101 in pheochromocytoma patients with SDHD mutation.Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism.Pheochromocytoma - update on disease management.Case of spontaneous regression of carotid body tumor in a SDHD mutant: a discussion on potential mechanisms based on a review of the literature.Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment optionsEANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.HRAS mutation prevalence and associated expression patterns in pheochromocytoma.Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomasClinical and genetic investigation of a multi-generational Chinese family afflicted with Von Hippel-Lindau diseaseTreatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas.Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.Familial pheochromocytomas and paragangliomas.Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations.From transcriptional profiling to tumor biology in pheochromocytoma and paraganglioma.Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
P2860
Q24312781-A303962C-2787-4BFD-9854-8880FF643A6CQ26782841-14A84E09-60B1-4BE5-A661-85B579865124Q28087343-8B5F1C73-3A0A-4063-BD66-FC82B3AF71A6Q30575178-95B007AE-A84F-460E-A58C-93693BDF623DQ33570108-68E8F85F-7D19-4443-A509-AD63B2BD3A33Q33590969-FC8A9FF6-C752-467E-8013-31259AA6A382Q33638286-8CE901EC-419D-4728-8BFD-24F6CD062CADQ33649025-BF2266CE-72D8-4C2D-9BC4-F1757343F309Q33844924-915BC741-04FA-4BE0-A8CA-11F087FA42C6Q34204524-30EC6B74-4C37-467D-92F0-5E1535AB0709Q34261618-A28B0031-E85F-4B9E-AFF4-1110F4620D36Q34410500-28EAD7B3-30BA-4C5C-A9E4-C332E9657903Q34469783-0AD83F21-C1F3-47B1-8882-F0CFF088933FQ34680693-364AB526-428D-495E-856E-A8E6EC12FC2BQ34692517-A51921BB-44EC-4462-8516-25B3C1F0EA5EQ34998940-EF1EDB54-73A9-4C43-A4FC-3440FACA7274Q35160825-DA046F7F-54B8-4B77-8051-BF40D2D75A7BQ35323457-A481768B-F679-4102-960B-F8216DF97E54Q35405433-79152BA9-25DB-4FB2-9F31-F5BD0F687DDEQ36247187-C82AC7F4-5775-4F3F-94FC-EA75451F8E2FQ36328071-FA853955-6500-4386-A4A2-256F74F406F8Q36406840-8CD0D422-9001-4712-AD8B-BC76064A0E70Q36458386-6FF6ECCA-5385-4205-A668-DCF8330DC37FQ36467722-68AF07B3-C287-4D7E-B229-3F76412344AAQ36694372-FB7AABB1-8605-4C7D-B0D8-774041CA84A2Q36730594-2640E574-C371-4DA8-A8EC-0F62E9EAAB1DQ36816186-57D7E63B-567B-4A6D-8993-7F8F8A17107CQ36932510-465955A2-CA0C-42BD-9B37-620F2199A6D6Q36982205-5C610836-F806-4D1C-B44A-60E5C811ED5FQ37025126-88755E4D-2259-4032-B7AE-2E2106980CBFQ37202015-BBC2D522-A3B9-4E55-97C1-6F8A5463C8C5Q37213634-A5E0C9B4-C37A-45E5-A467-61781DFB7A06Q37269244-02349412-1BED-4B4F-A847-47239BB7D49DQ37470890-590BF3E1-609C-43AC-8376-3437D66AF3EDQ37505830-FA5A738B-2185-4AE4-B296-4494DB2C44FCQ37568369-4CB8A744-F3AE-412D-B410-DEB8B71E6998Q37701667-01BF7FA8-FE9A-4F1D-9152-680466643C5AQ37714945-8365D03B-CA23-405B-A718-D2723EFCE501Q37983021-2CFED419-3027-43BA-B19E-3C7C50156BC4Q37994888-04076469-C8A7-4BC1-AD22-7F0379B6E70B
P2860
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
description
article
@en
im Juli 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2011
@uk
name
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@en
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@nl
type
label
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@en
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@nl
prefLabel
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@en
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@nl
P2093
P2860
P50
P356
P1476
Integrative genomic analysis r ...... chromocytoma and paraganglioma
@en
P2093
Annabelle Venisse
Aurélien de Reynies
Béatrice Parfait
Elodie Jouanno
Ingrid Laurendeau
Jérôme Bertherat
Laure Vescovo
Nelly Burnichon
Pierre-François Plouin
P2860
P304
P356
10.1093/HMG/DDR324
P577
2011-07-22T00:00:00Z